

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.58111685 |
| 2 | GDP-mannose metabolic process (GO:0019673) | 6.03986573 |
| 3 | respiratory chain complex IV assembly (GO:0008535) | 5.59219016 |
| 4 | signal peptide processing (GO:0006465) | 5.47727518 |
| 5 | negative regulation of granulocyte differentiation (GO:0030853) | 4.97411238 |
| 6 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.92233559 |
| 7 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.85705793 |
| 8 | myeloid leukocyte mediated immunity (GO:0002444) | 4.72459010 |
| 9 | cytochrome complex assembly (GO:0017004) | 4.65847933 |
| 10 | mannosylation (GO:0097502) | 4.60349646 |
| 11 | regulation of cellular respiration (GO:0043457) | 4.42304988 |
| 12 | neutrophil mediated immunity (GO:0002446) | 4.40712663 |
| 13 | ribosome assembly (GO:0042255) | 4.38647825 |
| 14 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 4.31557732 |
| 15 | cellular potassium ion homeostasis (GO:0030007) | 4.29660840 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.16807488 |
| 17 | telomere maintenance via recombination (GO:0000722) | 4.11256858 |
| 18 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.06639422 |
| 19 | sodium ion export (GO:0071436) | 3.99739754 |
| 20 | C-terminal protein lipidation (GO:0006501) | 3.95228954 |
| 21 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.93080048 |
| 22 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.92574026 |
| 23 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.92574026 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 3.90684762 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.90684762 |
| 26 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.83805233 |
| 27 | protein maturation by protein folding (GO:0022417) | 3.79077079 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.76186635 |
| 29 | negative regulation of growth of symbiont in host (GO:0044130) | 3.69167624 |
| 30 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.69167624 |
| 31 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.69167624 |
| 32 | regulation of growth of symbiont in host (GO:0044126) | 3.69167624 |
| 33 | DNA strand elongation (GO:0022616) | 3.67322281 |
| 34 | adenosine receptor signaling pathway (GO:0001973) | 3.64362860 |
| 35 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.63682022 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.52197338 |
| 37 | GPI anchor biosynthetic process (GO:0006506) | 3.46276573 |
| 38 | C-terminal protein amino acid modification (GO:0018410) | 3.38577315 |
| 39 | tongue development (GO:0043586) | 3.37537400 |
| 40 | GMP metabolic process (GO:0046037) | 3.36758660 |
| 41 | mitotic recombination (GO:0006312) | 3.31194319 |
| 42 | L-amino acid import (GO:0043092) | 3.27508493 |
| 43 | peptide hormone processing (GO:0016486) | 3.23734230 |
| 44 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.18529413 |
| 45 | postsynaptic membrane organization (GO:0001941) | 3.17147602 |
| 46 | developmental pigmentation (GO:0048066) | 3.15751756 |
| 47 | telomere maintenance via telomere lengthening (GO:0010833) | 3.15229297 |
| 48 | endosome to melanosome transport (GO:0035646) | 3.14781604 |
| 49 | endosome to pigment granule transport (GO:0043485) | 3.14781604 |
| 50 | central nervous system myelination (GO:0022010) | 3.11241603 |
| 51 | axon ensheathment in central nervous system (GO:0032291) | 3.11241603 |
| 52 | DNA replication initiation (GO:0006270) | 3.10983105 |
| 53 | potassium ion homeostasis (GO:0055075) | 3.09170520 |
| 54 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.07671190 |
| 55 | glutamate secretion (GO:0014047) | 3.01753773 |
| 56 | muscle filament sliding (GO:0030049) | 2.98609496 |
| 57 | actin-myosin filament sliding (GO:0033275) | 2.98609496 |
| 58 | synaptic vesicle maturation (GO:0016188) | 2.95440593 |
| 59 | regulation of oxidative phosphorylation (GO:0002082) | 2.95354293 |
| 60 | myelin maintenance (GO:0043217) | 2.94570007 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94510478 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94510478 |
| 63 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.93741954 |
| 64 | amino acid import (GO:0043090) | 2.93625369 |
| 65 | macroautophagy (GO:0016236) | 2.93323653 |
| 66 | positive regulation of protein export from nucleus (GO:0046827) | 2.92589775 |
| 67 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.92586640 |
| 68 | skeletal muscle contraction (GO:0003009) | 2.92281408 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.91638698 |
| 70 | pseudouridine synthesis (GO:0001522) | 2.91480607 |
| 71 | synaptic vesicle exocytosis (GO:0016079) | 2.91028763 |
| 72 | protein heterotetramerization (GO:0051290) | 2.90483123 |
| 73 | reactive oxygen species biosynthetic process (GO:1903409) | 2.90127461 |
| 74 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.88116734 |
| 75 | proteasome assembly (GO:0043248) | 2.87923874 |
| 76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.87887719 |
| 77 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.86565227 |
| 78 | potassium ion import (GO:0010107) | 2.85698571 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.85353888 |
| 80 | peptidyl-asparagine modification (GO:0018196) | 2.84768642 |
| 81 | killing of cells of other organism (GO:0031640) | 2.83301607 |
| 82 | disruption of cells of other organism (GO:0044364) | 2.83301607 |
| 83 | response to interferon-beta (GO:0035456) | 2.83101987 |
| 84 | respiratory burst (GO:0045730) | 2.82458747 |
| 85 | cotranslational protein targeting to membrane (GO:0006613) | 2.82062074 |
| 86 | negative regulation of inclusion body assembly (GO:0090084) | 2.81474946 |
| 87 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.80474457 |
| 88 | response to peptidoglycan (GO:0032494) | 2.79818473 |
| 89 | GPI anchor metabolic process (GO:0006505) | 2.79466951 |
| 90 | protein targeting to ER (GO:0045047) | 2.79102199 |
| 91 | neuronal ion channel clustering (GO:0045161) | 2.77431376 |
| 92 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.76915297 |
| 93 | regulation of skeletal muscle contraction (GO:0014819) | 2.75275096 |
| 94 | protein localization to endoplasmic reticulum (GO:0070972) | 2.73891161 |
| 95 | sequestering of metal ion (GO:0051238) | 2.73679654 |
| 96 | protein N-linked glycosylation (GO:0006487) | 2.72975849 |
| 97 | protein retention in ER lumen (GO:0006621) | 2.72472613 |
| 98 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72449906 |
| 99 | neutrophil activation involved in immune response (GO:0002283) | 2.72426127 |
| 100 | regulation of pigment cell differentiation (GO:0050932) | 2.69108075 |
| 101 | mitochondrion degradation (GO:0000422) | 2.69058308 |
| 102 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.68907555 |
| 103 | presynaptic membrane assembly (GO:0097105) | 2.66740504 |
| 104 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.66297765 |
| 105 | regulation of mitochondrial translation (GO:0070129) | 2.65848392 |
| 106 | androgen biosynthetic process (GO:0006702) | 2.65632646 |
| 107 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.65517432 |
| 108 | heme biosynthetic process (GO:0006783) | 2.65327435 |
| 109 | striated muscle contraction (GO:0006941) | 2.63919581 |
| 110 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.63377849 |
| 111 | mitochondrial calcium ion transport (GO:0006851) | 2.62829733 |
| 112 | tRNA methylation (GO:0030488) | 2.62708668 |
| 113 | negative regulation of phagocytosis (GO:0050765) | 2.62020133 |
| 114 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.60681418 |
| 115 | protein complex biogenesis (GO:0070271) | 2.59070487 |
| 116 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.59028482 |
| 117 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.59028482 |
| 118 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.58986687 |
| 119 | DNA replication checkpoint (GO:0000076) | 2.58931934 |
| 120 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.58287997 |
| 121 | nucleoside diphosphate catabolic process (GO:0009134) | 2.58176641 |
| 122 | regulation of cell communication by electrical coupling (GO:0010649) | 2.57758572 |
| 123 | facial nerve structural organization (GO:0021612) | 2.57107484 |
| 124 | barbed-end actin filament capping (GO:0051016) | 2.56172972 |
| 125 | metallo-sulfur cluster assembly (GO:0031163) | 2.55912059 |
| 126 | iron-sulfur cluster assembly (GO:0016226) | 2.55912059 |
| 127 | astrocyte differentiation (GO:0048708) | 2.55833353 |
| 128 | regulation of granulocyte differentiation (GO:0030852) | 2.55522986 |
| 129 | relaxation of muscle (GO:0090075) | 2.55328201 |
| 130 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.54886260 |
| 131 | neuronal action potential propagation (GO:0019227) | 2.53096329 |
| 132 | anterograde synaptic vesicle transport (GO:0048490) | 2.52679245 |
| 133 | cellular response to zinc ion (GO:0071294) | 2.52581096 |
| 134 | regulation of hexokinase activity (GO:1903299) | 2.52473425 |
| 135 | regulation of glucokinase activity (GO:0033131) | 2.52473425 |
| 136 | regulation of metalloenzyme activity (GO:0048552) | 2.50794115 |
| 137 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.49946847 |
| 138 | angiotensin maturation (GO:0002003) | 2.49943714 |
| 139 | cerebellar granule cell differentiation (GO:0021707) | 2.47384624 |
| 140 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.46307020 |
| 141 | cellular sodium ion homeostasis (GO:0006883) | 2.45970918 |
| 142 | cardiac muscle contraction (GO:0060048) | 2.42671106 |
| 143 | skeletal muscle adaptation (GO:0043501) | 2.40123445 |
| 144 | actin-mediated cell contraction (GO:0070252) | 2.39325160 |
| 145 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.36236508 |
| 146 | myofibril assembly (GO:0030239) | 2.35124353 |
| 147 | skeletal muscle fiber development (GO:0048741) | 2.32394039 |
| 148 | myotube differentiation (GO:0014902) | 2.31710774 |
| 149 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.31587547 |
| 150 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.29742753 |
| 151 | regulation of beta-amyloid formation (GO:1902003) | 2.27862561 |
| 152 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.27506400 |
| 153 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.27408522 |
| 154 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.25776886 |
| 155 | endothelial cell chemotaxis (GO:0035767) | 2.24628701 |
| 156 | relaxation of cardiac muscle (GO:0055119) | 2.24263178 |
| 157 | neuromuscular process controlling balance (GO:0050885) | 2.22312193 |
| 158 | regulation of inclusion body assembly (GO:0090083) | 2.20589792 |
| 159 | regulation of relaxation of muscle (GO:1901077) | 2.20053311 |
| 160 | fructose metabolic process (GO:0006000) | 2.19554608 |
| 161 | cell communication by electrical coupling (GO:0010644) | 2.18747676 |
| 162 | cortical actin cytoskeleton organization (GO:0030866) | 2.16360483 |
| 163 | astrocyte development (GO:0014002) | 2.15898798 |
| 164 | positive regulation of synapse maturation (GO:0090129) | 2.15898761 |
| 165 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.15505970 |
| 166 | actin filament-based movement (GO:0030048) | 2.15394843 |
| 167 | regulation of ARF protein signal transduction (GO:0032012) | 2.14565691 |
| 168 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.13716044 |
| 169 | neurotransmitter uptake (GO:0001504) | 2.13714350 |
| 170 | regulation of synapse maturation (GO:0090128) | 2.13708406 |
| 171 | response to thyroid hormone (GO:0097066) | 2.13073267 |
| 172 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.12140682 |
| 173 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.11749813 |
| 174 | creatine metabolic process (GO:0006600) | 2.11594251 |
| 175 | response to muscle activity (GO:0014850) | 2.10622008 |
| 176 | neurotransmitter secretion (GO:0007269) | 2.10191610 |
| 177 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.09815196 |
| 178 | apoptotic cell clearance (GO:0043277) | 2.08684268 |
| 179 | glycogen catabolic process (GO:0005980) | 2.07023747 |
| 180 | regulation of synaptic vesicle transport (GO:1902803) | 2.06801571 |
| 181 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.06731504 |
| 182 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.06731504 |
| 183 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.05706834 |
| 184 | metanephric nephron epithelium development (GO:0072243) | 2.05185992 |
| 185 | positive regulation of potassium ion transport (GO:0043268) | 2.04783782 |
| 186 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.04108565 |
| 187 | cell communication involved in cardiac conduction (GO:0086065) | 2.04108552 |
| 188 | regulation of early endosome to late endosome transport (GO:2000641) | 2.03797783 |
| 189 | muscle cell cellular homeostasis (GO:0046716) | 2.03336910 |
| 190 | positive regulation of astrocyte differentiation (GO:0048711) | 2.02634046 |
| 191 | activation of protein kinase A activity (GO:0034199) | 2.01205358 |
| 192 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.00959692 |
| 193 | monocyte differentiation (GO:0030224) | 2.00817122 |
| 194 | cell volume homeostasis (GO:0006884) | 2.00713101 |
| 195 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.00655924 |
| 196 | plasma membrane repair (GO:0001778) | 1.99984327 |
| 197 | muscle contraction (GO:0006936) | 1.99931352 |
| 198 | cell-cell junction maintenance (GO:0045217) | 1.99234603 |
| 199 | axon ensheathment (GO:0008366) | 1.98694256 |
| 200 | ensheathment of neurons (GO:0007272) | 1.98694256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.12470363 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.54658023 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.49216073 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.47957903 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.47076759 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.39398212 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.11863043 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.88698160 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.78387917 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.76689780 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.71335017 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.69311601 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60761695 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58337996 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.55881294 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51394405 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.50209967 |
| 18 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.45751827 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.39909800 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.38918354 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.35211642 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32884464 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32753123 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.32224040 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30958182 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.29076655 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28170104 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.24344589 |
| 29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.23455786 |
| 30 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22759878 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.19965387 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14120106 |
| 33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.11606016 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09353871 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.06380404 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.02904133 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99620782 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.99472590 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.98711922 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97997219 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96765988 |
| 42 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.93998611 |
| 43 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90388221 |
| 44 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.78897974 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.77905977 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77757452 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76763911 |
| 48 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.76046514 |
| 49 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.74843036 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72801517 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.72595495 |
| 52 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72401490 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71642662 |
| 54 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71237172 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.70238973 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69657008 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68801683 |
| 58 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68267274 |
| 59 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66825826 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65530293 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.60441487 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58692702 |
| 63 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58090243 |
| 64 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56789577 |
| 65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.56295330 |
| 66 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55467359 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54559651 |
| 68 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53872876 |
| 69 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.53767993 |
| 70 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.52641436 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.52501555 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.52463622 |
| 73 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.51746665 |
| 74 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50639946 |
| 75 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.50593115 |
| 76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.49581127 |
| 77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.48195574 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46743678 |
| 79 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.44780059 |
| 80 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43262715 |
| 81 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43262715 |
| 82 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42058508 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42058508 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.40764287 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40242339 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40015367 |
| 87 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38674449 |
| 88 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34253780 |
| 89 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33856930 |
| 90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33714509 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31937829 |
| 92 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.31322717 |
| 93 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30879821 |
| 94 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.30094851 |
| 95 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.29874863 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28688073 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.27985784 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26821597 |
| 99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.25784391 |
| 100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24172646 |
| 101 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23806899 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23456951 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.22202115 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21913144 |
| 105 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21881024 |
| 106 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21234096 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20813682 |
| 108 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18837376 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18539566 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18242634 |
| 111 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18053110 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17020364 |
| 113 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16681797 |
| 114 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15359649 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15299816 |
| 116 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14726327 |
| 117 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14266597 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14128358 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14032588 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13919556 |
| 121 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12851100 |
| 122 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12738137 |
| 123 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12413850 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10992534 |
| 125 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10145865 |
| 126 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09677504 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09558311 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09355508 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08989868 |
| 130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07223777 |
| 131 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06994672 |
| 132 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.06948335 |
| 133 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06898698 |
| 134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06505508 |
| 135 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06327428 |
| 136 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05983299 |
| 137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04927103 |
| 138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04799868 |
| 139 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03767107 |
| 140 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.03613275 |
| 141 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02420020 |
| 142 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01522506 |
| 143 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00278545 |
| 144 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00194109 |
| 145 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00026402 |
| 146 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.99530137 |
| 147 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99194453 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98544918 |
| 149 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98238443 |
| 150 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97695524 |
| 151 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97213260 |
| 152 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97123734 |
| 153 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94865845 |
| 154 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94515709 |
| 155 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93921365 |
| 156 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.93809375 |
| 157 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93736887 |
| 158 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93018854 |
| 159 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92926705 |
| 160 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91830088 |
| 161 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91797071 |
| 162 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91774398 |
| 163 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91508506 |
| 164 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91508506 |
| 165 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.91362818 |
| 166 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90977247 |
| 167 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.90942738 |
| 168 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.90919160 |
| 169 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90540606 |
| 170 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90151611 |
| 171 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.89905714 |
| 172 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89494746 |
| 173 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89360938 |
| 174 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88981979 |
| 175 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88726085 |
| 176 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88463139 |
| 177 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88060731 |
| 178 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88023142 |
| 179 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87791570 |
| 180 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87401920 |
| 181 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87064550 |
| 182 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87015671 |
| 183 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.86876002 |
| 184 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86445458 |
| 185 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86306888 |
| 186 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.85999343 |
| 187 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.85772933 |
| 188 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85671858 |
| 189 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83176472 |
| 190 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.82344936 |
| 191 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81862266 |
| 192 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.81742840 |
| 193 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81283251 |
| 194 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80764377 |
| 195 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.80723250 |
| 196 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80671965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.06922465 |
| 2 | MP0005174_abnormal_tail_pigmentation | 3.58077388 |
| 3 | MP0001188_hyperpigmentation | 3.50603642 |
| 4 | MP0000015_abnormal_ear_pigmentation | 3.47671681 |
| 5 | MP0003724_increased_susceptibility_to | 3.41043524 |
| 6 | MP0003690_abnormal_glial_cell | 3.18124257 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.08862167 |
| 8 | MP0001986_abnormal_taste_sensitivity | 3.02818037 |
| 9 | MP0005409_darkened_coat_color | 2.85302110 |
| 10 | MP0000751_myopathy | 2.81620533 |
| 11 | MP0000749_muscle_degeneration | 2.81468257 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.71131470 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.67784453 |
| 14 | MP0004270_analgesia | 2.63711100 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.61799826 |
| 16 | MP0003646_muscle_fatigue | 2.35288534 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.35207204 |
| 18 | MP0000920_abnormal_myelination | 2.26332707 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.26193791 |
| 20 | MP0000747_muscle_weakness | 2.25467254 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.24882815 |
| 22 | MP0002876_abnormal_thyroid_physiology | 2.22037302 |
| 23 | MP0002095_abnormal_skin_pigmentation | 2.21923880 |
| 24 | MP0003329_amyloid_beta_deposits | 2.20725243 |
| 25 | MP0004036_abnormal_muscle_relaxation | 2.20403337 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.11893000 |
| 27 | MP0008260_abnormal_autophagy | 2.07583043 |
| 28 | MP0001853_heart_inflammation | 2.01252016 |
| 29 | MP0002693_abnormal_pancreas_physiology | 2.00928710 |
| 30 | MP0003303_peritoneal_inflammation | 1.97068739 |
| 31 | MP0005379_endocrine/exocrine_gland_phen | 1.94230155 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.93926555 |
| 33 | MP0000372_irregular_coat_pigmentation | 1.93800745 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.91879453 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.91669343 |
| 36 | MP0003436_decreased_susceptibility_to | 1.91223817 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.90703834 |
| 38 | MP0004130_abnormal_muscle_cell | 1.90496626 |
| 39 | MP0008569_lethality_at_weaning | 1.90346353 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.90237775 |
| 41 | MP0009840_abnormal_foam_cell | 1.86161161 |
| 42 | MP0002064_seizures | 1.85420269 |
| 43 | MP0000681_abnormal_thyroid_gland | 1.81798946 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.80739214 |
| 45 | MP0008058_abnormal_DNA_repair | 1.79158728 |
| 46 | MP0003075_altered_response_to | 1.77498846 |
| 47 | MP0009785_altered_susceptibility_to | 1.76831299 |
| 48 | MP0004510_myositis | 1.73439905 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.70142984 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.69345080 |
| 51 | MP0002419_abnormal_innate_immunity | 1.67428376 |
| 52 | MP0000613_abnormal_salivary_gland | 1.65778476 |
| 53 | MP0004233_abnormal_muscle_weight | 1.65389145 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.64821390 |
| 55 | MP0000343_altered_response_to | 1.64633047 |
| 56 | MP0003634_abnormal_glial_cell | 1.61962682 |
| 57 | MP0005671_abnormal_response_to | 1.61366965 |
| 58 | MP0001944_abnormal_pancreas_morphology | 1.61225669 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.60084882 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.59915183 |
| 61 | MP0003635_abnormal_synaptic_transmissio | 1.58946874 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.58793794 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.58320137 |
| 64 | MP0005670_abnormal_white_adipose | 1.55983738 |
| 65 | MP0005025_abnormal_response_to | 1.55828386 |
| 66 | MP0002269_muscular_atrophy | 1.54512013 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.53202573 |
| 68 | MP0002971_abnormal_brown_adipose | 1.48920506 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.47504099 |
| 70 | MP0000604_amyloidosis | 1.47405235 |
| 71 | MP0004043_abnormal_pH_regulation | 1.45840250 |
| 72 | MP0003045_fibrosis | 1.44097885 |
| 73 | MP0003633_abnormal_nervous_system | 1.40626516 |
| 74 | MP0003136_yellow_coat_color | 1.40293440 |
| 75 | MP0009046_muscle_twitch | 1.39446909 |
| 76 | MP0005166_decreased_susceptibility_to | 1.38805176 |
| 77 | MP0004885_abnormal_endolymph | 1.37238695 |
| 78 | MP0001486_abnormal_startle_reflex | 1.35745478 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 1.34258518 |
| 80 | MP0003866_abnormal_defecation | 1.32587575 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.29653619 |
| 82 | MP0005620_abnormal_muscle_contractility | 1.29353602 |
| 83 | MP0002063_abnormal_learning/memory/cond | 1.28880764 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.28284040 |
| 85 | MP0000490_abnormal_crypts_of | 1.28169313 |
| 86 | MP0003880_abnormal_central_pattern | 1.27683571 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.27679718 |
| 88 | MP0002272_abnormal_nervous_system | 1.27324313 |
| 89 | MP0003879_abnormal_hair_cell | 1.26991574 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 1.26164541 |
| 91 | MP0003300_gastrointestinal_ulcer | 1.25994251 |
| 92 | MP0009745_abnormal_behavioral_response | 1.25959352 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 1.24464769 |
| 94 | MP0002106_abnormal_muscle_physiology | 1.24457437 |
| 95 | MP0002751_abnormal_autonomic_nervous | 1.24336263 |
| 96 | MP0005451_abnormal_body_composition | 1.24035888 |
| 97 | MP0005375_adipose_tissue_phenotype | 1.23950910 |
| 98 | MP0005666_abnormal_adipose_tissue | 1.23749841 |
| 99 | MP0005165_increased_susceptibility_to | 1.22125992 |
| 100 | MP0005464_abnormal_platelet_physiology | 1.20816860 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 1.18991944 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 1.18360286 |
| 103 | * MP0002420_abnormal_adaptive_immunity | 1.17539300 |
| 104 | MP0000371_diluted_coat_color | 1.16882991 |
| 105 | MP0001270_distended_abdomen | 1.16706784 |
| 106 | MP0002896_abnormal_bone_mineralization | 1.16241267 |
| 107 | MP0002735_abnormal_chemical_nociception | 1.16113297 |
| 108 | * MP0002723_abnormal_immune_serum | 1.16012828 |
| 109 | * MP0001819_abnormal_immune_cell | 1.15705917 |
| 110 | MP0001186_pigmentation_phenotype | 1.15312659 |
| 111 | MP0004084_abnormal_cardiac_muscle | 1.15300628 |
| 112 | MP0002972_abnormal_cardiac_muscle | 1.14758371 |
| 113 | MP0004484_altered_response_of | 1.13973537 |
| 114 | MP0000003_abnormal_adipose_tissue | 1.13788812 |
| 115 | MP0002075_abnormal_coat/hair_pigmentati | 1.11983370 |
| 116 | * MP0001502_abnormal_circadian_rhythm | 1.10847475 |
| 117 | MP0003186_abnormal_redox_activity | 1.09773370 |
| 118 | MP0002572_abnormal_emotion/affect_behav | 1.09128230 |
| 119 | MP0005171_absent_coat_pigmentation | 1.07423258 |
| 120 | MP0000013_abnormal_adipose_tissue | 1.07204750 |
| 121 | MP0006082_CNS_inflammation | 1.07032942 |
| 122 | MP0003631_nervous_system_phenotype | 1.05805051 |
| 123 | MP0005369_muscle_phenotype | 1.04983352 |
| 124 | MP0002090_abnormal_vision | 1.04729859 |
| 125 | MP0001984_abnormal_olfaction | 1.03596242 |
| 126 | MP0001765_abnormal_ion_homeostasis | 1.03147274 |
| 127 | MP0002452_abnormal_antigen_presenting | 1.02944059 |
| 128 | MP0000733_abnormal_muscle_development | 1.02622517 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 1.00427387 |
| 130 | MP0003091_abnormal_cell_migration | 1.00229445 |
| 131 | MP0006072_abnormal_retinal_apoptosis | 1.00218131 |
| 132 | MP0003828_pulmonary_edema | 0.99911039 |
| 133 | MP0002163_abnormal_gland_morphology | 0.98163257 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.97549735 |
| 135 | MP0003950_abnormal_plasma_membrane | 0.96377569 |
| 136 | MP0002229_neurodegeneration | 0.96224259 |
| 137 | MP0008469_abnormal_protein_level | 0.95942643 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.95832962 |
| 139 | MP0002909_abnormal_adrenal_gland | 0.95207150 |
| 140 | MP0000685_abnormal_immune_system | 0.94942639 |
| 141 | * MP0000716_abnormal_immune_system | 0.94733330 |
| 142 | MP0005636_abnormal_mineral_homeostasis | 0.92414070 |
| 143 | MP0005023_abnormal_wound_healing | 0.91757035 |
| 144 | MP0000858_altered_metastatic_potential | 0.91471422 |
| 145 | MP0001533_abnormal_skeleton_physiology | 0.91237583 |
| 146 | MP0008874_decreased_physiological_sensi | 0.90669433 |
| 147 | MP0003632_abnormal_nervous_system | 0.90522812 |
| 148 | MP0001970_abnormal_pain_threshold | 0.90489806 |
| 149 | MP0005330_cardiomyopathy | 0.90368449 |
| 150 | MP0001800_abnormal_humoral_immune | 0.89102344 |
| 151 | MP0005645_abnormal_hypothalamus_physiol | 0.88766483 |
| 152 | MP0000358_abnormal_cell_content/ | 0.87875448 |
| 153 | MP0004142_abnormal_muscle_tone | 0.87822299 |
| 154 | MP0001440_abnormal_grooming_behavior | 0.87014852 |
| 155 | MP0000750_abnormal_muscle_regeneration | 0.86526195 |
| 156 | * MP0002398_abnormal_bone_marrow | 0.85479062 |
| 157 | MP0004215_abnormal_myocardial_fiber | 0.85320146 |
| 158 | MP0002160_abnormal_reproductive_system | 0.84890839 |
| 159 | MP0003283_abnormal_digestive_organ | 0.84779693 |
| 160 | MP0003279_aneurysm | 0.84610260 |
| 161 | MP0003195_calcinosis | 0.84235435 |
| 162 | MP0006276_abnormal_autonomic_nervous | 0.83582154 |
| 163 | MP0005595_abnormal_vascular_smooth | 0.82794455 |
| 164 | MP0001790_abnormal_immune_system | 0.82651815 |
| 165 | MP0005387_immune_system_phenotype | 0.82651815 |
| 166 | MP0002078_abnormal_glucose_homeostasis | 0.82517454 |
| 167 | MP0001764_abnormal_homeostasis | 0.82322843 |
| 168 | MP0004381_abnormal_hair_follicle | 0.82222831 |
| 169 | MP0002933_joint_inflammation | 0.82057600 |
| 170 | MP0005535_abnormal_body_temperature | 0.81535787 |
| 171 | MP0002177_abnormal_outer_ear | 0.80735071 |
| 172 | * MP0002429_abnormal_blood_cell | 0.77789398 |
| 173 | MP0005257_abnormal_intraocular_pressure | 0.75684494 |
| 174 | MP0000689_abnormal_spleen_morphology | 0.75499835 |
| 175 | MP0010094_abnormal_chromosome_stability | 0.74992930 |
| 176 | MP0002928_abnormal_bile_duct | 0.74793744 |
| 177 | MP0006138_congestive_heart_failure | 0.73960789 |
| 178 | MP0002938_white_spotting | 0.73561776 |
| 179 | MP0008007_abnormal_cellular_replicative | 0.72874626 |
| 180 | MP0002066_abnormal_motor_capabilities/c | 0.72479668 |
| 181 | MP0005164_abnormal_response_to | 0.71569421 |
| 182 | MP0000631_abnormal_neuroendocrine_gland | 0.70694784 |
| 183 | MP0004147_increased_porphyrin_level | 0.66411469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 7.99651527 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 7.75141152 |
| 3 | Abnormal protein N-linked glycosylation (HP:0012347) | 6.06530222 |
| 4 | Abnormal protein glycosylation (HP:0012346) | 6.06530222 |
| 5 | Abnormal glycosylation (HP:0012345) | 6.06530222 |
| 6 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 6.06530222 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 5.43236709 |
| 8 | Nemaline bodies (HP:0003798) | 5.41806871 |
| 9 | Exercise-induced myalgia (HP:0003738) | 5.19409868 |
| 10 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.18382988 |
| 11 | Hypothermia (HP:0002045) | 4.43548898 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 4.32268894 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.95704179 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 3.92747273 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.81323908 |
| 16 | Muscle fiber splitting (HP:0003555) | 3.74419725 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 3.67298643 |
| 18 | Glomerulonephritis (HP:0000099) | 3.62721275 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.45000541 |
| 20 | Difficulty running (HP:0009046) | 3.41830633 |
| 21 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.40977690 |
| 22 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.40280800 |
| 23 | Hepatic necrosis (HP:0002605) | 3.31520830 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.29006521 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.29006521 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.29006521 |
| 27 | Late onset (HP:0003584) | 3.23300713 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 3.15059932 |
| 29 | Distal lower limb muscle weakness (HP:0009053) | 3.13469904 |
| 30 | Thyroid-stimulating hormone excess (HP:0002925) | 3.11710275 |
| 31 | Annular pancreas (HP:0001734) | 3.09033831 |
| 32 | Mutism (HP:0002300) | 3.08754031 |
| 33 | Ocular albinism (HP:0001107) | 3.08168740 |
| 34 | Myopathic facies (HP:0002058) | 3.06443889 |
| 35 | Hepatocellular necrosis (HP:0001404) | 3.05563319 |
| 36 | Bundle branch block (HP:0011710) | 3.05162046 |
| 37 | Thoracic kyphosis (HP:0002942) | 2.94059847 |
| 38 | Round ear (HP:0100830) | 2.93895347 |
| 39 | Axonal loss (HP:0003447) | 2.92726963 |
| 40 | Sex reversal (HP:0012245) | 2.89676543 |
| 41 | Abnormal sex determination (HP:0012244) | 2.89676543 |
| 42 | Myoglobinuria (HP:0002913) | 2.89071753 |
| 43 | Abnormality of magnesium homeostasis (HP:0004921) | 2.87687430 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.86352116 |
| 45 | Severe visual impairment (HP:0001141) | 2.84417806 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.83474754 |
| 47 | Cortical visual impairment (HP:0100704) | 2.83258261 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.83023592 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.80788305 |
| 50 | Exertional dyspnea (HP:0002875) | 2.79381376 |
| 51 | Spinal canal stenosis (HP:0003416) | 2.78212155 |
| 52 | Increased connective tissue (HP:0009025) | 2.77659414 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.77155410 |
| 54 | Action tremor (HP:0002345) | 2.76084792 |
| 55 | Rhabdomyolysis (HP:0003201) | 2.75612052 |
| 56 | Hypoglycemic coma (HP:0001325) | 2.75247330 |
| 57 | Hyperkalemia (HP:0002153) | 2.74973747 |
| 58 | Aplastic anemia (HP:0001915) | 2.72869986 |
| 59 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72051631 |
| 60 | Generalized aminoaciduria (HP:0002909) | 2.69462146 |
| 61 | Distal arthrogryposis (HP:0005684) | 2.68047543 |
| 62 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.66676582 |
| 63 | Frequent falls (HP:0002359) | 2.66552659 |
| 64 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.65206740 |
| 65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.65128103 |
| 66 | Neck muscle weakness (HP:0000467) | 2.61395684 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.61182413 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.60836217 |
| 69 | Iris hypopigmentation (HP:0007730) | 2.59964856 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58078740 |
| 71 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.57946305 |
| 72 | Ankle clonus (HP:0011448) | 2.57773665 |
| 73 | Complement deficiency (HP:0004431) | 2.57007446 |
| 74 | Abnormal number of erythroid precursors (HP:0012131) | 2.56034408 |
| 75 | Neuronal loss in central nervous system (HP:0002529) | 2.55145675 |
| 76 | Renal Fanconi syndrome (HP:0001994) | 2.53593022 |
| 77 | Thrombocytosis (HP:0001894) | 2.53044150 |
| 78 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.49926343 |
| 79 | Symptomatic seizures (HP:0011145) | 2.48394502 |
| 80 | Lipid accumulation in hepatocytes (HP:0006561) | 2.47559070 |
| 81 | Split foot (HP:0001839) | 2.46896535 |
| 82 | Diplopia (HP:0000651) | 2.45418771 |
| 83 | Abnormality of binocular vision (HP:0011514) | 2.45418771 |
| 84 | Rapidly progressive (HP:0003678) | 2.42396858 |
| 85 | Abnormality of the axillary hair (HP:0100134) | 2.40967155 |
| 86 | Abnormality of secondary sexual hair (HP:0009888) | 2.40967155 |
| 87 | Nuclear cataract (HP:0100018) | 2.35232517 |
| 88 | Microvesicular hepatic steatosis (HP:0001414) | 2.31254724 |
| 89 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.29199590 |
| 90 | Subaortic stenosis (HP:0001682) | 2.29199590 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27298437 |
| 92 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23275238 |
| 93 | Rigidity (HP:0002063) | 2.22078578 |
| 94 | Attenuation of retinal blood vessels (HP:0007843) | 2.21132140 |
| 95 | Cerebral aneurysm (HP:0004944) | 2.20622927 |
| 96 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20608466 |
| 97 | Foot dorsiflexor weakness (HP:0009027) | 2.19586274 |
| 98 | Recurrent abscess formation (HP:0002722) | 2.14792159 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 2.14239191 |
| 100 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.13801106 |
| 101 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.13801106 |
| 102 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.13731997 |
| 103 | Calf muscle hypertrophy (HP:0008981) | 2.13636999 |
| 104 | Dysostosis multiplex (HP:0000943) | 2.13151537 |
| 105 | Lower limb hyperreflexia (HP:0002395) | 2.11969239 |
| 106 | Muscle stiffness (HP:0003552) | 2.11958656 |
| 107 | Abnormal atrioventricular conduction (HP:0005150) | 2.11720304 |
| 108 | True hermaphroditism (HP:0010459) | 2.11159628 |
| 109 | Focal motor seizures (HP:0011153) | 2.10446318 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 2.09931293 |
| 111 | Heart block (HP:0012722) | 2.08974446 |
| 112 | Bulbar palsy (HP:0001283) | 2.08738525 |
| 113 | Increased cerebral lipofuscin (HP:0011813) | 2.08736603 |
| 114 | Mitochondrial inheritance (HP:0001427) | 2.06535191 |
| 115 | Chronic obstructive pulmonary disease (HP:0006510) | 2.05406228 |
| 116 | Obstructive lung disease (HP:0006536) | 2.05406228 |
| 117 | Decreased circulating renin level (HP:0003351) | 2.05329605 |
| 118 | Abnormality of the foot musculature (HP:0001436) | 2.05121543 |
| 119 | Hyperphosphatemia (HP:0002905) | 2.04564890 |
| 120 | Generalized tonic-clonic seizures (HP:0002069) | 2.03931328 |
| 121 | Ulnar deviation of the wrist (HP:0003049) | 2.03549888 |
| 122 | EMG: neuropathic changes (HP:0003445) | 2.03448303 |
| 123 | Hypoplasia of the fovea (HP:0007750) | 2.03151690 |
| 124 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.03151690 |
| 125 | IgM deficiency (HP:0002850) | 2.02632865 |
| 126 | Myositis (HP:0100614) | 2.02208854 |
| 127 | Broad face (HP:0000283) | 2.00814069 |
| 128 | Increased muscle lipid content (HP:0009058) | 2.00636298 |
| 129 | Abnormality of the calf musculature (HP:0001430) | 2.00506931 |
| 130 | Sudden death (HP:0001699) | 1.99750780 |
| 131 | Arterial tortuosity (HP:0005116) | 1.99473615 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99289323 |
| 133 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99034488 |
| 134 | Atonic seizures (HP:0010819) | 1.99009572 |
| 135 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.98630217 |
| 136 | Febrile seizures (HP:0002373) | 1.98170075 |
| 137 | Pancreatic fibrosis (HP:0100732) | 1.98005175 |
| 138 | Postural instability (HP:0002172) | 1.97759054 |
| 139 | Lower limb amyotrophy (HP:0007210) | 1.97531686 |
| 140 | Abnormality of the prostate (HP:0008775) | 1.95712575 |
| 141 | Abnormality of T cell physiology (HP:0011840) | 1.94150000 |
| 142 | Ventricular fibrillation (HP:0001663) | 1.90675537 |
| 143 | Progressive muscle weakness (HP:0003323) | 1.89233637 |
| 144 | Intention tremor (HP:0002080) | 1.88648466 |
| 145 | Abnormality of the fovea (HP:0000493) | 1.88190112 |
| 146 | Abnormality of the columella (HP:0009929) | 1.87616992 |
| 147 | Abnormality of complement system (HP:0005339) | 1.85734431 |
| 148 | Meningitis (HP:0001287) | 1.85553440 |
| 149 | Papilledema (HP:0001085) | 1.85452367 |
| 150 | Scanning speech (HP:0002168) | 1.85129128 |
| 151 | Pancreatic cysts (HP:0001737) | 1.84745343 |
| 152 | Increased CSF lactate (HP:0002490) | 1.84404317 |
| 153 | Microretrognathia (HP:0000308) | 1.84293032 |
| 154 | Recurrent bacterial skin infections (HP:0005406) | 1.83836460 |
| 155 | Abnormality of the periventricular white matter (HP:0002518) | 1.83349283 |
| 156 | Nephritis (HP:0000123) | 1.83307160 |
| 157 | Ventricular arrhythmia (HP:0004308) | 1.82901326 |
| 158 | Absence seizures (HP:0002121) | 1.82407181 |
| 159 | Pulmonary fibrosis (HP:0002206) | 1.82405903 |
| 160 | Myokymia (HP:0002411) | 1.80876175 |
| 161 | Abnormality of renal resorption (HP:0011038) | 1.79335594 |
| 162 | Progressive neurologic deterioration (HP:0002344) | 1.78578108 |
| 163 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.77177765 |
| 164 | Dysmetria (HP:0001310) | 1.77167267 |
| 165 | Dementia (HP:0000726) | 1.75772767 |
| 166 | Truncal ataxia (HP:0002078) | 1.74144153 |
| 167 | Vascular tortuosity (HP:0004948) | 1.74142386 |
| 168 | Capillary hemangiomas (HP:0005306) | 1.74008995 |
| 169 | Depression (HP:0000716) | 1.73007430 |
| 170 | Apathy (HP:0000741) | 1.71476057 |
| 171 | Mucopolysacchariduria (HP:0008155) | 1.71437888 |
| 172 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71437888 |
| 173 | Focal seizures (HP:0007359) | 1.70828316 |
| 174 | Petechiae (HP:0000967) | 1.70009033 |
| 175 | Tetraplegia (HP:0002445) | 1.69959885 |
| 176 | Atrioventricular block (HP:0001678) | 1.69869251 |
| 177 | Gowers sign (HP:0003391) | 1.69858798 |
| 178 | Spinal rigidity (HP:0003306) | 1.69627601 |
| 179 | Nonprogressive disorder (HP:0003680) | 1.69042276 |
| 180 | Flat occiput (HP:0005469) | 1.68996574 |
| 181 | Polar cataract (HP:0010696) | 1.68530579 |
| 182 | Stridor (HP:0010307) | 1.66676179 |
| 183 | Increased CSF protein (HP:0002922) | 1.66590226 |
| 184 | Increased serum lactate (HP:0002151) | 1.65272350 |
| 185 | Dicarboxylic aciduria (HP:0003215) | 1.64966879 |
| 186 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.64966879 |
| 187 | Type 2 muscle fiber atrophy (HP:0003554) | 1.64725993 |
| 188 | Difficulty climbing stairs (HP:0003551) | 1.64139093 |
| 189 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.63973153 |
| 190 | Stomatitis (HP:0010280) | 1.63880099 |
| 191 | Hyperparathyroidism (HP:0000843) | 1.63675906 |
| 192 | Scapular winging (HP:0003691) | 1.63355264 |
| 193 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.62132912 |
| 194 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.62132912 |
| 195 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.62132912 |
| 196 | Exercise intolerance (HP:0003546) | 1.60906391 |
| 197 | Chronic otitis media (HP:0000389) | 1.60649583 |
| 198 | Eczematoid dermatitis (HP:0000976) | 1.59841567 |
| 199 | Microcytic anemia (HP:0001935) | 1.59267670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK3 | 7.95363857 |
| 2 | TNIK | 7.16014068 |
| 3 | OBSCN | 3.83433285 |
| 4 | STK16 | 3.73557099 |
| 5 | PHKG2 | 3.63512863 |
| 6 | PHKG1 | 3.63512863 |
| 7 | CAMKK2 | 3.48656425 |
| 8 | LMTK2 | 3.32008609 |
| 9 | NLK | 2.76325184 |
| 10 | RIPK1 | 2.30214485 |
| 11 | EIF2AK2 | 2.28705810 |
| 12 | MKNK2 | 2.24352646 |
| 13 | FES | 2.18318324 |
| 14 | IRAK3 | 2.16911832 |
| 15 | TTN | 2.15482726 |
| 16 | IRAK4 | 2.08820284 |
| 17 | MAPK15 | 2.05226992 |
| 18 | MAP3K13 | 1.91981547 |
| 19 | FLT3 | 1.86565607 |
| 20 | TEC | 1.86021427 |
| 21 | DAPK2 | 1.74444243 |
| 22 | EPHA2 | 1.68727356 |
| 23 | MOS | 1.68681179 |
| 24 | TRIB3 | 1.65874677 |
| 25 | MAP3K9 | 1.65870054 |
| 26 | LATS2 | 1.62591559 |
| 27 | MAPK12 | 1.58401204 |
| 28 | INSRR | 1.57985367 |
| 29 | ZAK | 1.54648911 |
| 30 | MST1R | 1.52982862 |
| 31 | SCYL2 | 1.52902057 |
| 32 | MAP3K2 | 1.49012529 |
| 33 | TGFBR2 | 1.47324255 |
| 34 | PAK6 | 1.41487153 |
| 35 | CASK | 1.39485948 |
| 36 | PDK2 | 1.36527744 |
| 37 | VRK1 | 1.36048562 |
| 38 | CAMK2G | 1.35783364 |
| 39 | PIM2 | 1.33053382 |
| 40 | MARK1 | 1.32806572 |
| 41 | ERN1 | 1.32269127 |
| 42 | SIK1 | 1.24930970 |
| 43 | KIT | 1.21674158 |
| 44 | MAP3K3 | 1.21482717 |
| 45 | SGK3 | 1.19965426 |
| 46 | PASK | 1.18709314 |
| 47 | NTRK2 | 1.17382788 |
| 48 | NME2 | 1.15196515 |
| 49 | LIMK1 | 1.14651922 |
| 50 | TRPM7 | 1.14002899 |
| 51 | MKNK1 | 1.13540530 |
| 52 | MUSK | 1.12707115 |
| 53 | CAMK2B | 1.11914126 |
| 54 | DMPK | 1.07980829 |
| 55 | WEE1 | 1.06808914 |
| 56 | KSR2 | 1.05535134 |
| 57 | IRAK1 | 1.02117863 |
| 58 | SGK2 | 1.00889438 |
| 59 | MAP3K1 | 1.00854590 |
| 60 | EPHA4 | 0.99816222 |
| 61 | BTK | 0.99785300 |
| 62 | DDR2 | 0.99782076 |
| 63 | MAP2K7 | 0.99104852 |
| 64 | ACVR1B | 0.99099003 |
| 65 | NTRK1 | 0.98986606 |
| 66 | PIK3CG | 0.97987371 |
| 67 | MAPK7 | 0.96961701 |
| 68 | PRPF4B | 0.96199354 |
| 69 | PDPK1 | 0.93174518 |
| 70 | MAP3K7 | 0.92367119 |
| 71 | ROCK2 | 0.91557894 |
| 72 | SGK494 | 0.91064820 |
| 73 | SGK223 | 0.91064820 |
| 74 | PDGFRA | 0.90671147 |
| 75 | TESK1 | 0.90626240 |
| 76 | PKN1 | 0.89503611 |
| 77 | CAMK2D | 0.89460833 |
| 78 | PTK2 | 0.86126832 |
| 79 | CAMK1 | 0.85795264 |
| 80 | HIPK2 | 0.83490761 |
| 81 | BRSK2 | 0.81463119 |
| 82 | ROCK1 | 0.80868027 |
| 83 | NTRK3 | 0.79733294 |
| 84 | CAMKK1 | 0.78543341 |
| 85 | PRKAA2 | 0.78127303 |
| 86 | BCKDK | 0.78112393 |
| 87 | MARK2 | 0.77447025 |
| 88 | BLK | 0.77346208 |
| 89 | CDK19 | 0.76572574 |
| 90 | NEK6 | 0.75335309 |
| 91 | JAK1 | 0.74459028 |
| 92 | YES1 | 0.73600067 |
| 93 | MET | 0.73574162 |
| 94 | ZAP70 | 0.73284622 |
| 95 | PDK1 | 0.72989864 |
| 96 | CDK5 | 0.71065618 |
| 97 | CDC42BPA | 0.70987534 |
| 98 | GRK5 | 0.70258491 |
| 99 | TLK1 | 0.70127972 |
| 100 | STK38 | 0.69623929 |
| 101 | PRKD3 | 0.68967186 |
| 102 | ADRBK2 | 0.67273917 |
| 103 | CAMK2A | 0.66394390 |
| 104 | MAP2K1 | 0.65998205 |
| 105 | RIPK4 | 0.64347906 |
| 106 | IRAK2 | 0.63564133 |
| 107 | MAPK10 | 0.63531037 |
| 108 | SYK | 0.61727840 |
| 109 | MAPKAPK3 | 0.59279452 |
| 110 | LYN | 0.59063614 |
| 111 | SGK1 | 0.58154813 |
| 112 | PRKCH | 0.57582496 |
| 113 | KDR | 0.57503196 |
| 114 | STK24 | 0.56895091 |
| 115 | MAP2K3 | 0.56584508 |
| 116 | WNK3 | 0.56322000 |
| 117 | MAP3K12 | 0.54727741 |
| 118 | ICK | 0.54714523 |
| 119 | PRKAA1 | 0.52183118 |
| 120 | PDGFRB | 0.52154908 |
| 121 | PRKD1 | 0.51490952 |
| 122 | PAK4 | 0.51169064 |
| 123 | TAOK2 | 0.50776902 |
| 124 | DYRK3 | 0.50017356 |
| 125 | BRAF | 0.49467628 |
| 126 | PINK1 | 0.49101357 |
| 127 | BUB1 | 0.49086743 |
| 128 | CAMK1G | 0.48483117 |
| 129 | PRKG1 | 0.48471779 |
| 130 | FER | 0.48334051 |
| 131 | DAPK1 | 0.48332730 |
| 132 | JAK3 | 0.48177358 |
| 133 | RPS6KA4 | 0.47945379 |
| 134 | MAPK13 | 0.46848024 |
| 135 | TAOK3 | 0.46448877 |
| 136 | STK38L | 0.44972759 |
| 137 | MAP4K1 | 0.44895964 |
| 138 | SRPK1 | 0.44521334 |
| 139 | CSK | 0.44115308 |
| 140 | TBK1 | 0.43950207 |
| 141 | EPHB2 | 0.43939212 |
| 142 | TYK2 | 0.43883247 |
| 143 | IKBKE | 0.43541789 |
| 144 | EPHA3 | 0.43130899 |
| 145 | CDK8 | 0.42802545 |
| 146 | MAPK4 | 0.42758508 |
| 147 | CAMK1D | 0.40819405 |
| 148 | CAMK4 | 0.40704317 |
| 149 | RPS6KA2 | 0.39399856 |
| 150 | CDK3 | 0.39273545 |
| 151 | MATK | 0.39236929 |
| 152 | CDC7 | 0.39074392 |
| 153 | BMX | 0.38677668 |
| 154 | MAP3K14 | 0.38640640 |
| 155 | BMPR2 | 0.36527776 |
| 156 | UHMK1 | 0.36467415 |
| 157 | ATR | 0.35350169 |
| 158 | CCNB1 | 0.34705129 |
| 159 | IKBKB | 0.34561766 |
| 160 | CSF1R | 0.33821528 |
| 161 | MAP3K6 | 0.33296419 |
| 162 | TXK | 0.33217291 |
| 163 | BMPR1B | 0.32679150 |
| 164 | ARAF | 0.30719048 |
| 165 | LCK | 0.30524671 |
| 166 | EIF2AK1 | 0.28929883 |
| 167 | MAP2K6 | 0.28929100 |
| 168 | CDK7 | 0.28078847 |
| 169 | BRSK1 | 0.27581849 |
| 170 | PLK4 | 0.25306928 |
| 171 | ITK | 0.23592931 |
| 172 | PRKG2 | 0.21625168 |
| 173 | AURKA | 0.19850844 |
| 174 | ABL2 | 0.19560342 |
| 175 | PRKD2 | 0.17706598 |
| 176 | GRK7 | 0.16539513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 5.41303500 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.17256504 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.79586383 |
| 4 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.32281200 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.87025301 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.63722725 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.38701703 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.37052849 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.04191965 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.04061897 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98402044 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.95941343 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.93968221 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82014667 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78864362 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75614661 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.74774164 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69098630 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66400342 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.65819865 |
| 21 | * Circadian rhythm_Homo sapiens_hsa04710 | 1.64649122 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62492152 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.62111003 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56106579 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.55365695 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.55040505 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54968485 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.54923512 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53310439 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49795934 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44379925 |
| 32 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.44249681 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42570398 |
| 34 | Thyroid cancer_Homo sapiens_hsa05216 | 1.41528986 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.41431990 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.40824957 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39218834 |
| 38 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38330229 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.37108723 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35766549 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.32226424 |
| 42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.31851989 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.29672699 |
| 44 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.28847486 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28814031 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28486728 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27747025 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.25585787 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25579558 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.25011336 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23667663 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21749853 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19193705 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.18426373 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17766326 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.15981204 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15794242 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14023697 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.12104457 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 1.11787291 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11633278 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10320463 |
| 63 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09367848 |
| 64 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08653553 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03061108 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 1.02015656 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01965927 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01589647 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01493143 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.99035420 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.97636668 |
| 72 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95049933 |
| 73 | Nicotine addiction_Homo sapiens_hsa05033 | 0.94907118 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.94648800 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93253655 |
| 76 | Bile secretion_Homo sapiens_hsa04976 | 0.93145438 |
| 77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.91646504 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89923562 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89721267 |
| 80 | Insulin secretion_Homo sapiens_hsa04911 | 0.89248533 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88825783 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87855324 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87639736 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87464854 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87449048 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.86908966 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.86244100 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86232008 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85761428 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85153354 |
| 91 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84380769 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83544575 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83283545 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83275592 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82836279 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82653708 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.81712867 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80939517 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80169943 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79984810 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79514647 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79468705 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77047904 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76925991 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.76786681 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76370384 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75831827 |
| 108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75006999 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74477509 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73634740 |
| 111 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73376848 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73222161 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72610608 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.70600569 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70405825 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69604772 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.67777774 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67444799 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.66831335 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66312051 |
| 121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65795324 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.65217347 |
| 123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65110356 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64654189 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.64183280 |
| 126 | Melanogenesis_Homo sapiens_hsa04916 | 0.63775680 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63689899 |
| 128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63420503 |
| 129 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63366601 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62943809 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62724243 |
| 132 | Legionellosis_Homo sapiens_hsa05134 | 0.62597832 |
| 133 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61485178 |
| 134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61039638 |
| 135 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58990863 |
| 136 | ABC transporters_Homo sapiens_hsa02010 | 0.58788452 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.58075166 |
| 138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57942631 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57937005 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.57565690 |
| 141 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56805959 |
| 142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54876469 |
| 143 | Pertussis_Homo sapiens_hsa05133 | 0.54344798 |
| 144 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53981544 |
| 145 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53963098 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53902128 |
| 147 | Measles_Homo sapiens_hsa05162 | 0.53656438 |
| 148 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53482997 |
| 149 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53400549 |
| 150 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52303826 |
| 151 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52231175 |
| 152 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51763384 |
| 153 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51050293 |
| 154 | Asthma_Homo sapiens_hsa05310 | 0.50434075 |
| 155 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47923395 |
| 156 | Phototransduction_Homo sapiens_hsa04744 | 0.47824586 |
| 157 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47677964 |
| 158 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47326786 |
| 159 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46645504 |
| 160 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45078060 |
| 161 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44067434 |
| 162 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42858754 |
| 163 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42442850 |
| 164 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42031841 |
| 165 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41223519 |
| 166 | Cell cycle_Homo sapiens_hsa04110 | 0.40326594 |
| 167 | Alcoholism_Homo sapiens_hsa05034 | 0.38366792 |
| 168 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38344959 |
| 169 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37576308 |
| 170 | Malaria_Homo sapiens_hsa05144 | 0.37170902 |
| 171 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37092766 |
| 172 | Tuberculosis_Homo sapiens_hsa05152 | 0.36584528 |
| 173 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35555111 |
| 174 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33184285 |
| 175 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32255905 |
| 176 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31939912 |
| 177 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30065577 |
| 178 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29864876 |
| 179 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28399350 |
| 180 | RNA transport_Homo sapiens_hsa03013 | 0.27451590 |
| 181 | Allograft rejection_Homo sapiens_hsa05330 | 0.27338242 |
| 182 | Taste transduction_Homo sapiens_hsa04742 | 0.27105935 |
| 183 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26971420 |

